将英格兰伤寒病例的流行病学与基因组数据关联以指导临床管理和公共卫生行动
研究探索将英格兰每例伤寒患者增强监测问卷数据与相应伤寒沙门菌分离株的基因组测序数据(含抗菌药物耐药谱)关联的可行性。在关联数据后分析显示,86.9%病例使用抗生素,近半数分离株存在环丙沙星耐药突变;作者建议医护人员更透明系统地记录抗生素处方细节,并将处方数据与基因组耐药谱整合以监测治疗影响和促进最佳实践。
要点
- 86.9%(1230/1415)的伤寒病例使用了抗生素,一半病例说明了抗生素类别。
- 45.5%(644/1415)的分离株存在环丙沙星耐药突变。
- 作者建议医护人员更透明系统地记录抗生素处方细节。
核心结论
- 由于患者访谈数据缺失比例高,作者推荐医护人员在初级和二级保健中更透明、系统地记录抗生素处方细节。
- 作者认为,将处方数据与病原体基因组耐药谱在个体患者层面整合,可监测治疗对临床结局的影响并实时促进最佳实践。
研究设计与样本
- 研究将英格兰每例伤寒病例的增强监测患者问卷数据与相应伤寒沙门菌分离株的基因组测序数据(含抗菌药物耐药谱)进行关联。
主要发现
- 86.9%(1230/1415)的病例使用了抗生素,其中630/1239例说明所用抗生素类别,316/630例使用头孢菌素类。
- 抗生素联合治疗的使用随症状严重程度增加。
- 45.5%(644/1415)的分离株存在环丙沙星耐药突变。
- 根据基因组耐药谱推断对推荐一线抗菌药物敏感的伤寒沙门菌分离株,从居住在最不贫困地区个体中分离的比例为15.4%(26/169),从最贫困地区个体中分离的比例为7.2%(32/442)。
临床怎么用
- 作者建议医护人员在初级和二级保健中更透明、系统地记录抗生素处方细节。
局限性
- 作者指出,患者访谈数据缺失比例高,因此推荐更透明和系统化的记录方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore the feasibility of linking data from enhanced surveillance patient questionnaires from each enteric fever case in England with genome sequencing data, including antimicrobial resistance (AMR) profiles, from the corresponding isolate of typhoidal salmonellae. METHODS: After linking data we interrogated the merged dataset and assessed the utility of passive surveillance data to match and monitor antimicrobial treatment regimens in enteric fever patients with the AMR profiles of the infectious agent. RESULTS: A high proportion of cases were given antibiotics (n = 1230/1415; 86.9%); half of the cases stated the class of antibiotic they were given (n = 630/1239) and half were prescribed cephalosporins (n = 316/630). Reported treatment with a combination of antibiotics increased with symptom severity. Nearly half of isolates (n = 644/1415; 45.5%) had mutations conferring resistance to ciprofloxacin. Based on genome-derived AMR profiles, typhoidal salmonellae isolates inferred to be susceptible to the recommended first-line antimicrobials were twice as likely to be isolated from individuals residing in the least deprived areas compared with the most deprived (n = 26/169; 15.4% versus n = 32/442; 7.2%). CONCLUSIONS: Due to the high proportion of missing data obtained from patient interviews, we recommend a more transparent and systematic approach to recording the antibiotic prescription details by healthcare professionals in primary and secondary care. A more robust approach to data capture at this point in the care pathway would enable us to audit inconsistencies in the prescribing algorithms across England and ensure equitable treatment across all sections of society. Integrating prescribing data with the genome-derived AMR profiles of the causative agent at the individual patient level provides an opportunity to monitor the impact of treatment on clinical outcomes, and to promote best practice in real time.
引用
- Buczkowska M, Chattaway MA, Jenkins C, et al. Linking epidemiological and genomic data in cases of enteric fever in England to inform clinical management and public health action. J Antimicrob Chemother. 2024. PMID: 38873828. doi:10.1093/jac/dkae148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。